These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9601125)

  • 1. The discovery, development and clinical applications of granulocyte colony-stimulating factor.
    Dale DC
    Trans Am Clin Climatol Assoc; 1998; 109():27-36; discussion 36-8. PubMed ID: 9601125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical studies of granulocyte colony stimulating factor (G-CSF).
    Scarffe JH; Kamthan A
    Cancer Surv; 1990; 9(1):115-30. PubMed ID: 1703454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applications of granulocyte colony-stimulating factor: an update and summary.
    Hübel K; Engert A
    Ann Hematol; 2003 Apr; 82(4):207-13. PubMed ID: 12707722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low doses of colony-stimulating factors lead to resolution of neutropenia in cancer patients through increased levels of dihydrofolate reductase.
    Iqbal MP; Burney IA
    Pak J Pharm Sci; 2014 Mar; 27(2):245-8. PubMed ID: 24577909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
    Fernández-Varón E; Villamayor L
    Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases.
    Hübel K; Dale DC; Engert A; Liles WC
    J Infect Dis; 2001 Jan; 183(2):321-328. PubMed ID: 11112098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human granulocyte colony-stimulating factor (G-CSF), the premier granulopoietin: biology, clinical utility, and receptor structure and function.
    Tkatch LS; Tweardy DJ
    Lymphokine Cytokine Res; 1993 Dec; 12(6):477-88. PubMed ID: 7510132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on generation and mobilization of neutrophils in cyclophosphamide-treated neutropenic mice.
    Hattori K; Orita T; Oheda M; Tamura M; Ono M
    In Vivo; 1996; 10(3):319-27. PubMed ID: 8797034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
    Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC
    Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
    Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
    Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony stimulating factor (G-CSF): biology and clinical status.
    Jakubowski A; Gabrilove J
    Cancer Biother Radiopharm; 1996 Feb; 11(1):5-20. PubMed ID: 10851516
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity.
    Wiltschke C; Krainer M; Nanut M; Wagner A; Linkesch W; Zielinski CC
    J Interferon Cytokine Res; 1995 Mar; 15(3):249-53. PubMed ID: 7584671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant canine granulocyte colony-stimulating factor on white blood cell production in clinically normal and neutropenic dogs.
    Mishu L; Callahan G; Allebban Z; Maddux JM; Boone TC; Souza LM; Lothrop CD
    J Am Vet Med Assoc; 1992 Jun; 200(12):1957-64. PubMed ID: 1379221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of granulocyte-macrophage and granulocyte colony-stimulating factors in neutrophil transendothelial migration: comparison with interleukin-8.
    Smith WB; Gamble JR; Vadas MA
    Exp Hematol; 1994 Mar; 22(3):329-34. PubMed ID: 7509293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.